Literature DB >> 4816460

Interferon administered in the cerebrospinal space and its effect on rabies in rabbits.

M Ho, C Nash, C W Morgan, J A Armstrong, R G Carroll, B Postic.   

Abstract

Because combined administration of intramuscular and intravenous interferon has been partially successful in the incubationary treatment of rabies, the effect of direct interferon administration into the cerebrospinal fluid space was tested. After injecting 1,800 U of interferon into the cisterna magna or the lateral ventricle, periodic samples, obtained by cisternal taps, showed that 1 to 5% remained after 24 h, as opposed to the known clearance of interferon from the bloodstream to this level within minutes. The distributions of interferon and (131)I-labeled albumin were similar as demonstrated by kinetics of clearance monitored over 24 h. Beginning with and after experimental infection of rabbits, daily intraventricular injections of one million units of interferon were given for as long as 3 weeks. Interferon was prepared from cell culture fluids after pressure dialysis and chromatography on Sephadex G-100. This intensive treatment did not prevent encephalitis, but prolonged the length of the incubation period by one- to two-thirds. The outcome after intraventricular administration was not as favorable as when one million units equally divided between intramuscular and intravenous injections were given at the time of challenge. Interferon administered in the subarachnoid space in this fashion is apparently inadequate to protect the rabbit against rabies. Its role as an adjunct measure, or other methods of administration in the nervous system, remains to be examined.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4816460      PMCID: PMC414800          DOI: 10.1128/iai.9.2.286-293.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

2.  Interferon in rabbit brain, cerebrospinal fluid and serum following administration of polyinosinic-polycytidylic acid.

Authors:  F Cathala; S Baron
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

3.  Protection of rabbits against experimental rabies of poly I-poly C.

Authors:  P Fenje; B Postic
Journal:  Nature       Date:  1970-04-11       Impact factor: 49.962

Review 4.  Physiology of the choroid plexus.

Authors:  H F Cserr
Journal:  Physiol Rev       Date:  1971-04       Impact factor: 37.312

Review 5.  Interferon induction in cancer: with some observations on the clinical effects of poly 1:C.

Authors:  C W Young
Journal:  Med Clin North Am       Date:  1971-05       Impact factor: 5.456

6.  Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex.

Authors:  P Fenje; B Postic
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

7.  [In vivo inhibition of rabies virus multiplication by an endogenous interferon].

Authors:  P Atanasiu; M Barroeta; H Tsiang; S Favre
Journal:  Ann Inst Pasteur (Paris)       Date:  1970-12

8.  Cerebral ventricular infusions in unrestrained rats.

Authors:  C A Goodrich; B Greehey; T B Miller; J R Pappenheimer
Journal:  J Appl Physiol       Date:  1969-01       Impact factor: 3.531

9.  Characterization of virus- and endotoxin-induced interferons obtained from the serum and urine of rabbits.

Authors:  Y H Ke; M Ho
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Effect of administered interferon on rabies in rabbits.

Authors:  B Postic; P Fenje
Journal:  Appl Microbiol       Date:  1971-09
View more
  5 in total

1.  Effect of administered human interferon on experimental rabies in monkeys.

Authors:  J Hilfenhaus; H E Karges; E Weinmann; R Barth
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Exogenous interferon prolongs survival of rabies infected mice.

Authors:  S Mehta; S Roy; S Mukherjee; N Yadav; N Patel; A Chowdhary
Journal:  Virusdisease       Date:  2015-08-14

3.  Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies.

Authors:  E A Obbens; L G Feun; M E Leavens; N Savaraj; D J Stewart; J U Gutterman
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

4.  Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon.

Authors:  E Weinmann; M Majer; J Hilfenhaus
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.